## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran
โฆ LIBER โฆ
Selegiline, fluoxetine, and depression in Parkinson's disease
โ Scribed by Juan Carlos Garcia-Monco; Angel Padierna; Marian Gomez Beldarrain
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 134 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Selegiline and mortality in Parkinson's
โ
Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 489 KB
๐ 2 views
Fluoxetine in Parkinson's disease
โ
J. A. Simons
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 237 KB
Selegiline, pregnancy, and Parkinson's d
โ
Andreas Kupsch; Dr. Wolfgang H. Oertel
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 246 KB
Selegiline and mortality in Parkinson's
โ
A. J. Lees; J. Head; Y. Ben Shlomo
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 266 KB
๐ 2 views
Selegiline and lymphocyte superoxide dis
โ
John Kushleika; Dr. Harvey Checkoway; James S. Woods; Jai-Dong Moon; Terri Smith
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 356 KB
๐ 2 views
Subthreshold depression in Parkinson's d
โ
Daniel A. Nation; Heather L. Katzen; Spyridon Papapetropoulos; Blake K. Scanlon;
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 86 KB
๐ 2 views
## Abstract ## Objective It is estimated that 40% of patients with Parkinson's disease (PD) are clinically depressed, however, little is known about the frequency and associated features of subthreshold depression in PD. The current study sought to determine the prevalence of subthreshold depressi